Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSCs-Exos for moderate-to-severe active ulcerative colitis
NCT06853522Phase 1Not yet recruiting
- Sponsor
- Shanghai East Hospital
- Start
- May 2025
- Primary completion
- Apr 2027
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of human umbilical cord mesenchymal stem cell-derived exosomes in ulcerative colitis (UC) (2 arms), sponsored by Shanghai East Hospital. Primary endpoint: Mayo Score at 12 weeks. Planned start May 2025; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cell-derived exosomes
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06853522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06853522.